Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.

Potent antiretroviral therapy (ART) suppresses HIV-1 viral replication and results in decreased morbidity and mortality. However, prolonged treatment is associated with drug-induced toxicity, emergence of drug-resistant viral strains, and financial constraints. Structured therapeutic interruptions (...

Full description

Bibliographic Details
Main Authors:	Oxenius, A, Price, D, Günthard, H, Dawson, S, Fagard, C, Perrin, L, Fischer, M, Weber, R, Plana, M, García, F, Hirschel, B, McLean, A, Phillips, R
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
by: Oxenius, A, et al.
Published: (2002)

Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load.
by: Oxenius, A, et al.
Published: (2002)

A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
by: Fagard, C, et al.
Published: (2003)

Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy.
by: Oxenius, A, et al.
Published: (2002)

Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load.
by: Oxenius, A, et al.
Published: (2001)

Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.
by: Viktor von Wyl, et al.
Published: (2011-01-01)

Supervised Treatment Interruptions Fail to Control HIV-1 Viremia.
Published: (2004-11-01)

Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.
by: Plana, M, et al.
Published: (2004)

Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.
by: Joos, B, et al.
Published: (2005)

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
by: Hurst, J, et al.
Published: (2015)

HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load.
by: Oxenius, A, et al.
Published: (2004)

Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS.
by: Scherer, A, et al.
Published: (2004)

Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection.
by: Oxenius, A, et al.
Published: (2001)

No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection.
by: Fryer, H, et al.
Published: (2009)

Cross-staining of cytotoxic T lymphocyte populations with peptide-MHC class I multimers of natural HIV-1 variant antigens.
by: Oxenius, A, et al.
Published: (2001)

Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.
by: Oxenius, A, et al.
Published: (2001)

Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruption
by: Thembi Mdluli, et al.
Published: (2024-06-01)

HIV - Interpreted, intervened, interrupted . . .?
by: Damle S
Published: (2007-06-01)

HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.
by: Scriba, T, et al.
Published: (2005)

HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.
by: Scriba, T, et al.
Published: (2005)

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.
by: Wolbers, M, et al.
Published: (2007)

59 Interrupting HIV treatment in cure research: scientific and ethical considerations
by: S. Garner, et al.
Published: (2016-07-01)

Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.
by: Ellen Van Gulck, et al.
Published: (2012-01-01)

Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
by: Price, D, et al.
Published: (1999)

Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections
by: Barnes, E, et al.
Published: (2010)

Treatment Interruptions in Chronic HIV Infection.
Published: (2004-12-01)

Human immunodeficiency virus (HIV)-specific T helper responses fail to predict CD4+ T cell decline following short-course treatment at primary HIV-1 infection.
by: Fox, J, et al.
Published: (2008)

Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
by: Oxenius, A, et al.
Published: (2004)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2002)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2002)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
by: Samual A. Garner, et al.
Published: (2017-04-01)

Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption
by: Matthew Pace, et al.
Published: (2022-08-01)

Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
by: Tracy R Glass, et al.
Published: (2012-01-01)

Cellular Factors Targeting HIV-1 Transcription and Viral RNA Transcripts
by: Rayhane Nchioua, et al.
Published: (2020-04-01)

Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection.
by: Michael Huber, et al.
Published: (2006-11-01)

Baseline inducible HIV P24 is associated with viral control during interferon-α monotherapy with ART interruption
by: L.J. Montaner, et al.
Published: (2019-12-01)

Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.
by: Altfeld, M, et al.
Published: (2001)

Lymph Node Cellular and Viral Dynamics in Natural Hosts and Impact for HIV Cure Strategies
by: Nicolas Huot, et al.
Published: (2018-04-01)

Workflow Interruptions and Failed Action Regulation in Surgery Personnel
by: Achim Elfering, et al.
Published: (2014-03-01)

Reconsidering early HIV treatment and supervised treatment interruptions.
by: Richard A Koup
Published: (2004-11-01)